Avid Bioservices Inc (CDMO)
12.30
+0.05
(+0.41%)
USD |
NASDAQ |
Nov 22, 16:00
12.29
-0.01
(-0.08%)
After-Hours: 20:00
Avid Bioservices Revenue (TTM): 142.36M for July 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| July 31, 2024 | 142.36M |
| April 30, 2024 | 139.91M |
| January 31, 2024 | 136.74M |
| October 31, 2023 | 140.94M |
| July 31, 2023 | 150.30M |
| April 30, 2023 | 149.27M |
| January 31, 2023 | 140.69M |
| October 31, 2022 | 134.18M |
| July 31, 2022 | 125.54M |
| April 30, 2022 | 119.60M |
| January 31, 2022 | 115.98M |
| October 31, 2021 | 106.28M |
| July 31, 2021 | 101.23M |
| April 30, 2021 | 95.87M |
| January 31, 2021 | 80.81M |
| October 31, 2020 | 72.59M |
| July 31, 2020 | 69.84M |
| April 30, 2020 | 59.70M |
| January 31, 2020 | 64.21M |
| October 31, 2019 | 64.40M |
| July 31, 2019 | 56.27M |
| April 30, 2019 | 53.60M |
| January 31, 2019 | 43.49M |
| October 31, 2018 | 36.53M |
| July 31, 2018 | 39.13M |
| Date | Value |
|---|---|
| April 30, 2018 | 53.62M |
| January 31, 2018 | 64.58M |
| October 31, 2017 | 68.51M |
| July 31, 2017 | 79.10M |
| April 30, 2017 | 57.63M |
| January 31, 2017 | 58.18M |
| October 31, 2016 | 54.14M |
| July 31, 2016 | 40.30M |
| April 30, 2016 | 44.36M |
| January 31, 2016 | 35.21M |
| October 31, 2015 | 34.18M |
| July 31, 2015 | 30.96M |
| April 30, 2015 | 26.78M |
| January 31, 2015 | 23.95M |
| October 31, 2014 | 22.16M |
| July 31, 2014 | 23.21M |
| April 30, 2014 | 22.40M |
| January 31, 2014 | 20.18M |
| October 31, 2013 | 23.34M |
| July 31, 2013 | 22.12M |
| April 30, 2013 | 21.68M |
| January 31, 2013 | 19.49M |
| October 31, 2012 | 15.74M |
| July 31, 2012 | 13.83M |
| April 30, 2012 | 15.23M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
59.70M
Minimum
Apr 2020
150.30M
Maximum
Jul 2023
112.95M
Average
119.60M
Median
Apr 2022
Revenue (TTM) Benchmarks
| MEI Pharma Inc | -- |
| Altimmune Inc | 0.052M |
| Catalent Inc | 4.422B |
| NovaBay Pharmaceuticals Inc | 13.84M |
| Palatin Technologies Inc | -- |